GSK_Annual_Report_2021

Notes to the Standalone Financial Statements for the year ended March 31, 2021 (contd.) Annual Report 2020-21 133 Note 46 : Leases Future contractual charges on leases: The table below provides details regarding the contractual maturities of lease liabilities as at March 31, 2021 on an undiscounted basis: ( ` in lakhs) 0-1 years 1-2 years 2-3 years 3-4 years 4-5 years Above 5 years 14,35.27 10,50.32 6,33.70 2,56.70 84.27 - Right of use asset ( ` in lakhs) Particulars Buildings Balance as on April 1, 2020 39,33.57 Additions 7,77.85 Less: Depreciation (15,84.99) Balance as on March 31, 2021 31,26.43 Other financial lease liabilities ( ` in lakhs) Particulars Buildings Lease liabilities recognised as at April 1, 2020 41,66.30 Additions 7,77.04 Add: Interest accrued during the period 3,18.15 Less: Payments (18,01.23) Lease liabilities recognised as at March 31, 2021 34,60.26 Current lease liabilities 14,35.27 Non current lease liabilities 20,24.99 Borrowing rate - discounting rate used by the Company The lessee’s weighted average incremental borrowing rate applied to the lease liabilities was 7.26% to 7.59% Note 47 : Earnings per share ( ` in lakhs) Year ended March 31, 2021 Year ended March 31, 2020 Profit for the year Rupees in lakhs 357,56.76 110,05.26 Weighted average number of shares Nos. 169,406,034 169,406,034 Earnings per share before Exceptional items (Basic and Diluted) ` 31.32 26.69 Earnings per share after Exceptional items (Basic and Diluted) ` 21.11 6.50 Face value per share ` 10 10